These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36304002)

  • 1. Dynamic Perceived HIV Risk and Sexual Behaviors Among Young Women Enrolled in a PrEP Trial in Kenya: A Qualitative Study.
    Ngure K; Thuo N; Ogello V; Kiptinness C; Kamolloh K; Burns BFO; Mugo NR; Bukusi EA; Garrison L; Baeten JM; Haberer JE
    Front Reprod Health; 2021; 3():637869. PubMed ID: 36304002
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of SMS reminders on PrEP adherence in young Kenyan women (MPYA study): a randomised controlled trial.
    Haberer JE; Bukusi EA; Mugo NR; Pyra M; Kiptinness C; Oware K; Garrison LE; Thomas KK; Musinguzi N; Morrison S; Anderson PL; Ngure K; Baeten JM;
    Lancet HIV; 2021 Mar; 8(3):e130-e137. PubMed ID: 33662265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.
    Camlin CS; Koss CA; Getahun M; Owino L; Itiakorit H; Akatukwasa C; Maeri I; Bakanoma R; Onyango A; Atwine F; Ayieko J; Kabami J; Mwangwa F; Atukunda M; Owaraganise A; Kwarisiima D; Sang N; Bukusi EA; Kamya MR; Petersen ML; Cohen CR; Charlebois ED; Havlir DV
    AIDS Behav; 2020 Jul; 24(7):2149-2162. PubMed ID: 31955361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
    Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motivations for Reducing Other HIV Risk-Reduction Practices if Taking Pre-Exposure Prophylaxis: Findings from a Qualitative Study Among Women in Kenya and South Africa.
    Corneli A; Namey E; Ahmed K; Agot K; Skhosana J; Odhiambo J; Guest G
    AIDS Patient Care STDS; 2015 Sep; 29(9):503-9. PubMed ID: 26196411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing young Kenyan women's willingness to engage in a peer-delivered HIV self-testing and referral model for PrEP initiation: A qualitative formative research study.
    McGowan M; Casmir E; Wairimu N; Mogere P; Jahn A; Ngure K; Ortblad KF; Roche SD
    Front Public Health; 2022; 10():932948. PubMed ID: 36276357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "I Just Decided to Stop:" Understanding PrEP Discontinuation Among Individuals Initiating PrEP in HIV Care Centers in Kenya.
    Ongolly FK; Dolla A; Ngure K; Irungu EM; Odoyo J; Wamoni E; Peebles K; Mugwanya K; Mugo NR; Bukusi EA; Morton J; Baeten JM; O'Malley G
    J Acquir Immune Defic Syndr; 2021 May; 87(1):e150-e158. PubMed ID: 33492024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Being able to do whatever you wanna do as a woman is important:" a qualitative exploration of contraception as a frame of reference for HIV prevention with PrEP.
    Murphy EC; Danvers A; Zamudio AR; Avila K; Proehl M; Gonzalez-Argoti T; Mantell JE; Bauman LJ; Dolan SM
    Reprod Health; 2022 Apr; 19(1):92. PubMed ID: 35392943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV self-testing and oral pre-exposure prophylaxis are empowering for sex workers and their intimate partners: a qualitative study in Uganda.
    Mujugira A; Nakyanzi A; Kasiita V; Kamusiime B; Nalukwago GK; Nalumansi A; Twesigye CC; Muwonge TR; Baeten JM; Wyatt MA; Haberer JE; Ware NC
    J Int AIDS Soc; 2021 Sep; 24(9):e25782. PubMed ID: 34473405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sexual risk context among the FEM-PrEP study population in Bondo, Kenya and Pretoria, South Africa.
    Headley J; Lemons A; Corneli A; Agot K; Ahmed K; Wang M; Odhiambo J; Skhosana J; Tharaldson J; Van Damme L; MacQueen K;
    PLoS One; 2014; 9(9):e106410. PubMed ID: 25229403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I wish to remain HIV negative": Pre-exposure prophylaxis adherence and persistence in transgender women and men who have sex with men in coastal Kenya.
    Kimani M; van der Elst EM; Chirro O; Wahome E; Ibrahim F; Mukuria N; de Wit TFR; Graham SM; Operario D; Sanders EJ
    PLoS One; 2021; 16(1):e0244226. PubMed ID: 33465090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased condom use among key populations using oral PrEP in Kenya: results from large scale programmatic surveillance.
    Manguro GO; Musau AM; Were DK; Tengah S; Wakhutu B; Reed J; Plotkin M; Luchters S; Gichangi P; Temmerman M
    BMC Public Health; 2022 Feb; 22(1):304. PubMed ID: 35164707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Episodic Use of Pre-Exposure Prophylaxis Among Young Cisgender Women in Siaya County, Kenya.
    Corneli A; Perry B; Ngoje DO; Molokwu N; Strack R; Agot K
    AIDS Patient Care STDS; 2022 Oct; 36(10):379-388. PubMed ID: 36286578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
    PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial.
    Songtaweesin WN; Kawichai S; Phanuphak N; Cressey TR; Wongharn P; Saisaengjan C; Chinbunchorn T; Janyam S; Linjongrat D; Puthanakit T;
    J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25564. PubMed ID: 32869511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Pre-Exposure Prophylaxis Adherence in Young Women in Kenya.
    Haberer JE; Mugo N; Bukusi EA; Ngure K; Kiptinness C; Oware K; Garrison LE; Musinguzi N; Pyra M; Valenzuela S; Thomas KK; Anderson PL; Thirumurthy H; Baeten JM
    J Acquir Immune Defic Syndr; 2022 Mar; 89(3):251-260. PubMed ID: 35147580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-level Factors Driving Pre-exposure Prophylaxis Non-initiation Among Young Women at High Risk for HIV in Kenya.
    Katz IT; Ngure K; Kamolloh K; Ogello V; Okombo M; Thuo NB; Owino E; Garrison LE; Lee YS; Nardell MF; Anyacheblu C; Bukusi E; Mugo N; Baeten JM; Haberer JE;
    AIDS Behav; 2023 Jan; 27(1):106-118. PubMed ID: 35930203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.